The human microbiome has been a hot topic over the last decade, with research pointing to disrupted bacterial communities as culprits for a host of maladies including irritable bowel syndrome, eczema, and autoimmune diseases. ...
Nov 28, 2022
0
39
Victoria Male, a digestion and metabolism professor at Imperial College London, has published a Perspectives piece in the journal Science addressing reports of COVID-19 vaccines having various impacts on menstruation. In ...
A University of Kentucky Markey Cancer Center researcher's team developed new chemical compounds that show promise as a potential anticancer therapy to treat aggressive tumors.
Oct 27, 2022
0
9
A new study has revealed significant racial disparities in how quickly minorities with the most common form of lung cancer receive potentially lifesaving radiation therapy compared with their white counterparts.
Oct 25, 2022
0
1
A team led by Prof Kiavash Movahedi (VUB, VIB) has mapped in detail how the immune system acts against pathogens invading the brain. The findings shed new light on host-pathogen interactions and the long-term consequences ...
Oct 12, 2022
0
26
As COVID-19 wreaks havoc across the globe, one characteristic of the infection has not gone unnoticed. The disease is heterogeneous in nature with symptoms and severity of the condition spanning a wide range. The medical ...
Oct 5, 2022
0
11
The Laboratory of Neuroimmunology of the Institute of Experimental Medicine, Budapest (IEM), Hungary, led by Ádám Dénes, describes the presence of a direct interaction site between microglial cells and the cell body of ...
Sep 20, 2022
0
77
Alzheimer's disease, a devastating neuro-degenerative condition that causes dementia, affects more than 30 million people worldwide and remains an illness for which there is no cure.
Sep 20, 2022
0
0
Disease-free survival (DFS) does not differ with adjuvant nivolumab plus ipilimumab (NIVO+IPI) compared with placebo in patients with localized renal cell carcinoma (RCC) at high risk for postnephrectomy relapse, according ...
Sep 14, 2022
0
9
Long-lasting immune cells that specifically recognize the SARS-CoV-2 virus were found in the noses of people who were infected following vaccination. These virus-specific T cells, which were not present in those who had only ...
Sep 9, 2022
0
57
